Highlights –
- Seoul District Court acquitted Kolon Life executives on Friday.
- The two executives allegedly made fraudulent reports in its gene therapy drug.
- A senior director at the clinical development team is made to pay a fine of 5 million won.
- Cho and Kim were indicted on suspected illegalities in the development and sales of Invossa.
On Friday, the ....
Tags : SOUTH KOREA DRUGMAKING COMPANY, SEOUL DISTRICT COURT, KOLON LIFE EXECUTIVES, INVOSSA, CELL AND GENE THERAPY, OSTEOARTHRITIS, SOUTH KOREA MINISTRY OF FOOD AND DRUG SAFETY,
comments (0)